Company news
Pulike Biological Engineering, Inc. Class A (SSE:603566) news
Pulike Biological Engineering, Inc. Class A news releases on 6ix. Latest, Sep 16, 2026: "Pulike Biological Engineering, Inc."Announcement on Change of Sponsor…
Press releases & updates
"Pulike Biological Engineering, Inc."Announcement on Change of Sponsor Representative for Continuous Supervision and Guidance
September 15, 2026
"Pulike Biological Engineering, Inc."Announcement on Obtaining New Veterinary Drug Registration Certificate by Subsidiary
September 14, 2026
"Pulike Biological Engineering, Inc."Announcement on Convening the 2026 Semi-annual Performance Briefing
August 24, 2026
"Pulike Biological Engineering, Inc."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
August 20, 2026
"Pulike Biological Engineering, Inc."Announcement on the Controlled Subsidiary Being Approved to Produce Foot-and-Mouth Disease Vaccine (SAT 1)
July 21, 2026
"Pulike Biological Engineering, Inc."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
June 30, 2026
Announcement on Terminating Some Investment Projects Financed by Raised Funds
June 14, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 8, 2026
Announcement on Obtaining New Veterinary Drug Registration Certificate
June 5, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 21, 2026
Announcement on Applying to Bank for Comprehensive Credit Line
April 28, 2026
Announcement on Resolutions of the 1st Meeting of the 6th Board of Directors
March 6, 2026
Announcement on Resolutions of the 23rd Meeting of the 5th Board of Directors
February 6, 2026
Earnings Preannouncement for 2025
January 20, 2026
Announcement on Estimated Daily Related Party Transactions in 2026
January 15, 2026
Announcement on Subsidiary Obtaining New Veterinary Drug Registration Certificate
January 13, 2026
Announcement on Progress in Subscription of ZOPOMED Equity Held by CITIC Agriculture
December 16, 2025
Announcement on the Proposed Subscription of ZOPOMED Equity Held by CITIC Agriculture and Asset Acquisition
December 2, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
November 27, 2025
Announcement on Convening the Q3 2025 Performance Briefing
October 30, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
October 10, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
September 16, 2025
Announcement on Change of Sponsor Representative for Continuous Supervision
August 29, 2025
Announcement on Semi-annual Profit Distribution Plan for 2025
August 28, 2025
Announcement on Redemption at Maturity of Idle Raised Funds Used for Cash Management
August 22, 2025
Semi-annual Earnings Preannouncement for 2025
July 11, 2025
Announcement on the Subsidiary Obtaining New Veterinary Drug Registration Certificate
June 23, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 4, 2025
Announcement on Completing Cancellation of Some Special Accounts for Raised Funds
May 22, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 16, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Henan Jurisdiction
May 15, 2025
Announcement on 2024 Annual Profit Distribution Plan
April 24, 2025
Announcement on the Results of Shareholding Reduction by Shareholders
February 12, 2025
Annual Earnings Preannouncement for 2024
January 17, 2025
Announcement on Share Reduction Plan for Shareholders
January 9, 2025
Announcement on Resolution of the 11th Meeting of the 5th Board of Supervisors
January 3, 2025
Announcement on the Implementation Results of Share Repurchase and Changes in Shares
November 1, 2024
Announcement on the Completion of Special Account Cancellation for Partial Raised Funds
October 30, 2024
Announcement on Convening the Q3 2024 Performance Briefing
October 29, 2024
Announcement on Progress in Share Repurchase
October 8, 2024
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024
September 19, 2024
Announcement on Completing Deregistration of Wholly-owned Subsidiary
September 3, 2024
Announcement on the Progress of Share Repurchase
September 2, 2024
Announcement on Resolution of the 13th Meeting of the 5th Board of Directors
August 29, 2024